DEVLIES PHARMA
Timeline
36 events since 2005Board
Filings
Financial
Permits
Establishments
Address
20062008201020122014201620182020202220242026
The 2026 accounts are due by 31-01-2027.
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0877804765
Annual accounts 2025 filed PDFabbreviated format · 47 days before the deadline
Environmental permit granted Change of use · decided by Kortrijk
2024
Annual accounts 2024 filed PDFabbreviated format · 32 days before the deadline
2023
Annual accounts 2023 filed PDFabbreviated format · 44 days before the deadline
1 director appointed, 1 resignation resigns · . appointed · acts as permanent representative · General meeting of 02-12-20224 points ▸
- General meeting of 02-12-2022
- resigns as director
- . appointed as director
- acts as permanent representative
2022
Annual accounts 2022 filed PDFabbreviated format · 32 days before the deadline
Company renamed from Apotheek Leys to Devlies Pharma changes role from sole manager to director · . resigns as manager · DP appointed as director · General meeting of 13-04-20229 points ▸
- General meeting of 13-04-2022
- Name change, Devlies Pharma
- resigns as sole manager
- appointed as director, not named in the articles
- . resigns as manager
- DP appointed as director, not named in the articles
- acts as permanent representative
- Discharge granted to (manager)
- Discharge granted to . (manager)
- The deed holds 5 more points.
2021
Annual accounts 2021 filed PDFabbreviated format · 41 days before the deadline
2020
Annual accounts 2020 filed PDFabbreviated format · 31 days before the deadline
2019
Annual accounts 2019 filed PDFabbreviated format · 46 days before the deadline
Back to profit net €19 The net result is €19, after one loss-making year.
Annual accounts 2018 filed PDFabbreviated format · 7 days before the deadline
2018
Weakest financial year net -€21,328 The net result drops to -€21,328, the lowest from 2007 to 2025. It recovers the following year.
Annual accounts 2017 filed PDFabbreviated format · on the deadline day
2017
Highest result from 2007 to 2025 net €35,354 ▲40.8% The operating result of €46,686 and the net result of €35,354 are both a record.
2016
Annual accounts 2016 filed PDFabbreviated format · 36 days before the deadline
Annual accounts 2015 filed PDFabbreviated format · 16 days before the deadline
2015
Registered office moved within AalbekeThe registered office moved from Ommegangstraat 9 te 8511 Aalbeke to Moeskroensesteenweg 81 te 8511 Aalbeke · Board meeting of 31-03-20152 points ▸
- Board meeting of 31-03-2015
- The registered office moved to Moeskroensesteenweg 81 te 8511 Aalbeke
- The deed holds 1 more point.
Annual accounts 2014 filed PDFabbreviated format · 4 days before the deadline
2014
Back to profit net €3,468 The net result is €3,468, after 2 loss-making years.
Annual accounts 2013 filed PDFabbreviated format · 1 day before the deadline
2013
Annual accounts 2012 filed PDFabbreviated format · 11 days late
2012
Annual accounts 2011 filed PDFabbreviated format · 10 days late
2011
Back to profit net €58 The net result is €58, after one loss-making year.
Liquidity doubles current ratio 1.12 The current ratio rises from 0.56 to 1.12. Short-term debt falls from €526,414 to €265,754.
2 managers appointed, 2 resignations (manager) and (manager) resign · and act as permanent representatives · (manager) and . (manager) appointed · General meeting of 24-12-20108 points ▸
- General meeting of 24-12-2010
- resigns as manager
- acts as permanent representative
- resigns as manager
- General meeting of 23-12-2010
- appointed as manager
- . appointed as manager
- acts as permanent representative
Annual accounts 2010 filed PDFabbreviated format · 4 days before the deadline
2 managers appointed (manager) and (manager) · acts as permanent representative · General meeting of 23-12-20104 points ▸
- General meeting of 23-12-2010
- appointed as manager
- appointed as manager
- acts as permanent representative
2009
Annual accounts 2009 filed PDFabbreviated format · 38 days before the deadline
New manager appointed, resigned · and act as permanent representatives · General meeting of 23-07-20095 points ▸
- General meeting of 23-07-2009
- resigns as manager
- acts as permanent representative
- appointed as manager
- acts as permanent representative
Equity above €200,000 equity €201,590 ▲4.2% With a profit in every financial year since 2007, equity grows to €201,590.
2008
Annual accounts 2008 filed PDFabbreviated format · 32 days before the deadline
Annual accounts 2007 filed PDFabbreviated format · 7 days before the deadline
2006
First establishment D Pharma, Moeskroensesteenweg 81, Kortrijk
2005
Incorporation PDFpublished on 21-12-2005
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank